Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

28 cell.center

12th World AIDS Conference

- Keyword

Abstract

-Keyword

Abstract

ACS)/HIV RNA, CD4+
vation of restored body
us (JCV) DNA in blood
nt/Significance of CD4
n Lagos, Nigeria/Sickle
e/Dynamics of CD4+ T
2 on viral kinetics and T
0/Characterization of T
1/Clinical trials of stem
on prior to AIDS/CD4+
8 and total lymphocyte
itudinal study of CD8 T
odified CD4 and CD8 T
A) in 1996-1997/Body
n promotes gain in body
s associated with body
weight (TBW) and body
1 viral load and CD4+ T
an HIV patient/Plasma
/Use of monitored CD4
ogenic roles of type 2 T
e defect of natural killer
educing PC12 neuronal
elated to programmed
one/Increases in body
brain barrier endothelial
arker for HIV disease/T
ng of HIV to permissive cell

pism for human colonic
keleton of HIV-infected
ith CD4+ counts >400
atients with >500 CD4
ulture of HIV-1-infected
y a CD4 count of <200
D45RO+ and CD45RA+
n naive and activated T
ematopoietic progenitor
sus circulating CD4+ T
eration in blood CD4+ T
lecules on circulating T
sion (LT-NP)/CD4 Thl
V-1-infection of CD8+ T
esion kinase in CD4+ T
f renal tubular epithelial
alysis of HIV-1 infected
ly infected primary Th2
eral blood mononuclear
der cell death of CD8 T
ed apoptosis of CD4 T
gpl20-treated CD4+ T
utely infected-reservoir
ral blood mononuclear
IP1 a) in mononuclear
e HIV CD8+ cytotoxic T
on in primary human T
servoir of HIV-1 in CD4
e patients with CD4+ T
lasma and lymph node
1 replication in reservoir
etanus toxoid specific T
ed, allogeneic dendritic
eral blood mononuclear
4+ T lymphocyte >500
8 and CD38 by CD8+ T
ytes from bone marrow
ion of peripheral blood
AIDS patients with CD4
duced by mononuclear
V-1 gp120 and neuronal
ase of cd45ra+ t-helper
Detection of memory T
ral blood mononuclear
ediates in HIV-infected
IV viral load and CD4 T
bacterial and lymphoid
and blood mononuclear
expression in lymphoid
ercentage of apoptotic
nted with human CD4+
n HIV gpl60-specific T

count, and immune activation markers 506*/32167
mass (BCM) and phase angle after dis 32182
sub-populations and plasma of HIV+ in 32210
count and HIV viral load on CMV retinit 32243
anaemia and the risk of HIV infection in 33207
recovery in a large cohort treated with 41179
reconstitution in lymphoid tissues of as 41228
expressed chimeric receptors with anti 41233
gene therapy for HIV-1/Clinical trials o 41241
decline despite maintenance of stable 42152
counts to opportunistic infections in PH 42189
activation and viral load in HIV-infecte 42190
s leads to improved T cell survival and t 42321
mass (BCM) in HIV-infected (HIV+) m 42333
mass in HIV patients with weight loss/ 42336
mass in weight-stable HIV+ men with 42339
mass (BCM)/A retrospective study on 42340
subset in AIDS patients/Correlation be 60122
granuloma presenting as transverse m 60176
counts: Predictions of the AIDS epide 60237
responses on Cryptococcus neoforma 60314
activity in AIDS patients/Interleukin (IL 60325
line viability/A pentapeptide from HIV- 60334
death and accepted markers of diseas 60393
mass of patients with HIV associated 60489
receptors by HIV/Modulation of huma 60794
HLA-DR surface expression as a surro 60864
s is coordinated by interactions of gpl2 11114
and astrocytes/The common molecu 11118
as the transportation system of viral s 11137
//Il and viral load >5000 copies/ml/C 286*/12204
/mm3/Indinavir (IDV) in combination 12311
/Drug combination studies on MKC-4 12362
/gL/AIDS diagnosis by an opportunist 13214
in HIV-infected children, observation 13364
in blood and lymph nodes in patients r 269*/21112
(CD34+) of HIV-1 infected patients/T 21118
in seronegative controls/Increased e 21119
during HIV infection and treatment/N 21121
of HIV infected individuals/CD80 and 21125
specific for HIV-1 antigens are associ 21126
in vivo/HHV-6-independent HIV-1-inf 21130
by macrophage-tropic HIV envelope/ 55*/21135
involving Fas sensitization and ice-pr 21137
/HIV-1 infection induces alterations in 21152
and cell lines/Triggering of CD30 enh 21153
from chronically immune activated in 21156
induced by CD4 crosslinking (XL) of 274*/21159
from HIV+ patients is proportional to 21165
/Either mithocondrial damage or Fas 21166
/Human rlL-16 exerts potent HIV-sup 21185
of the patients infected with human i 21188
by mycobacterium tuberculosis durin 21189
epitopes/A polytope vaccine strategy 21193
/Effect of a gpl20-depleted inactivate 21212
in infants and children receiving HAA 22358
counts from 200 to 500/ttl and plasm 22383: The Quadri-96 Trial/Antiviral effect o 22397
by the safe immunomodulator murab 22424
/Effect of HIV-1 infection on chemoki 31141
/Generation of HIV-epitope-specific 31150
(PBMCs) from HIV-2+ individuals resi 31154
/prL/HIV-specific cytotoxic T lymphoc 31158
in HIV infection correlates with viral lo 116*/31170
cultures of AIDS patients/Enhanced 31187
(PBMCs) in HIV+ women and HIV-co 31196
count below 50 treated with combine 32149
from HIV-1 infected individuals induc 32200
/Shared antigenic epitopes on the V3 32217
/Highly active antiretroviral therapy ( 32317
in HIV+ individuals: Cytokine produci 216*/41103
and lymphoid tissues/Highly sensitiv 41133
treated with protease inhibitors/Accu 41184
in the mucosa-associated lymphoid ti 41185

/HIV infection inhibitors: Carbohydrat 41204
/Comparison of protease mutations i 41217
/CD38 stimulation exerts antiviral effe 41234
in HIV infected patients/lnterleukin-2 41235
and challenged with HIV1/Passive i 41243
from HIV-infected individuals/Immun 41244

tion of HIV-1-producing by ELISPOT (Enzyme-Linked Immun 42131
eripheral mononuclear during anti-HIV therapies/The chang 42174
to viral load and CD4 T as prognostic indicators/Plasma imm 42181
African settings/CD4 T phenotyping by flow cytometry: A qua 42182
ease/CD45 activity in T: A new surrogate marker of HIV disea 42183
he CD38 subset of CD8 predicts progression to AIDS in long-t 42191
ral blood mononuclear at term/Phosphorylation rate of 3'-azi 508*/42258
odified CD4 and CD8 T leads to improved T cell survival and t 42321
obilization of CD34+ from the bone marrow of HIV-1 infect 42323
+ men with CD4 < 200 /mm3: CPCRA 038/Protein intake is a 42339
an blood mononuclear from HIV infected patients in Argentin 42368
cted patients with CD4 < 75/mm3: An updated decision anal 43481
n in chronically infected /Anti-inflammatory alkaloid cepharan 60049
3 loop in viral entry into analyzed with 3 different anti-CXCR- 60161
oxide in HIV-1-infected /Apoptotic activity of nitric oxide in HI 60255
ents with 50-250 CD4 /mm3/Subgroup analysis of clinical a 60358
ces expressed in CD4+ /Broad spectrum resistance to HIV-1 60375
es/Infection of dendritic with different HIV-1 primary isolates/I 60404
IV replication/CD8+ exposed to B7.2 but not B7.1 during a 60406
rus replication in CD4+ naturally or acutely infected by HIV/C 60407
bition of HIV-1 by CD8+ from seropositive individuals is antige 60414
f HIV in the myocardial in a large population of HIV-positive s 60434
thway in HIV-infected T /The role of the stress-signaling path 60461
us replication in human /Thiosemicarbazone-derivatives inhi 60651
xpression in monocytic /Inhibitory influences of a-MSH pepti 60685
son of number of CD4+ to number of viral RNA copies in sera 60721
ction by lung and blood from HIV-seropositive patients and H 60787
or uninfected lymphoid /Effects of exogenous Nef and Tat pr 60872
NA viral load and CD4 T count/Quadritherapy including RTV/ 60966
nary TB/AIDS patients/ Cellular immune responses to mycobacter 31206
MEA in vitro and in vivo/ pharmacology of the antiviral age 554*/41175
V-1 infected Ugandans/ immune responses in HIV-1 infect 60382
tract/Co-receptors and cellular targets for HIV-1 in the human fem 10*/11106
ges of infection/HIV-1 RNA load arise in late stage of HIV 11158
velope induces strong immune responses in Macaques/ 11241
n induces alterations in gene expression: High density cD 21152
e/Antibody-dependent cytotoxicity (ADCC) in HIV-1 infect 31152
ating mothers/Study of and humoral immune factors in col 31163
viral therapy/Improved immunity in acute HIV-1 infection f 115*/31177
up of PPD skin test and immune response in a high risk gr 31207
uckles without affecting zinc finger proteins/Targeting anti 41187
y without impairment of proliferation/Efficacy of aminooxy 59*/41231
evels in plasma/HIV-1 infectious load in peripheral blood: 42176
with an autogenous HIV /viral therapeutic vaccine (ATV) usi 60312
m national surveys and censuses /The impact of HIV on mortality i 24189
at an urban US Medical Center, 1991-1996/Tuberculosis (TB) in 22135
ital ng Maynila Medical, an HIV/AIDS service center of Ma 22486
Diagnosis and Therapy in Warsaw, Poland/Community-ac 41170
onal Blood Transfusion (NBTC) in Abidjan/Psychosocial c 60220
eterans Affairs Medical /Predictors of resource utilization in 60341
a large, urban medical center who have taken nelfinavir in the pas 12392
HIV patients in a health of low complexity and limited resour 12437
p in an ambulatory care /HIV reactive patients with follow-u 13105
e d Vavoua" in the west of C6te d'lvoire, 430 km from Abidja 13557
an urban day treatment /Quality of life correlates at an urba 14350
fects of WF10/A single, phase 2 study evaluating the effect 22423
r, an HIV/AIDS service of Manila/Local government respo 22486
f activity of a reference in Rome/HIV infection among trans 570*/23534
t a university medical hospital in a small city/Changing de 24114
R) in a day care health (DCHC)/lntravitreal followed by ora 32244
-city community health (CHC)/Highly active antiretroviral t 32334
ot-line and counselling in Egypt/Experience of the establis 33264
or testing HIV in a social (1988-1996)/Analysis of 5098 dem 33304
mitted Diseases (STD) /Information-education-communica 33310
blematic of a screening in Burkina Faso: The case of the ce 33328
at a primary care health in a poor neighborhood of Rosario, 33330
hop reproductive health in Angeles City/Developing a one-s 33431
ot-line and counselling in Egypt/"Lessons learned from the 33459
nducted on 1997 in the province of Cameroon/Influence of 34129
f the anonimous testing users/Characterization of the anoni 34179
Yaounde/Creation of a for AIDS orphans in Yaounde/Crea 34255
1 Monitor~ assay/Multi- evaluation of the ultra sensitive Roc 42143
ents of an AIDS referral in SAo Paulo, Brazil/Important redu 42319
sts at an urban medical during the era of heart/Changes in 442*/42430

stance AIDS/STD pilot for young people/Sanitary strategie 43213
/HIV patients to health level requires health care reform im 43519
ed diseases at a referral of Karachi/Pattern of sexually trans 60243
ending a HIV reference in Rome/HIV infection among indivi 60257
nt AI-Nadjma (the star): A great advantage in social psycho 60424
attending in a reference in Vit6ria, Brazil/Profile of heterose 60707